Globally, Non-Alcoholic Fatty Liver Disease (NAFLD) is a growing concern, impacting a significant portion of the population.

Liver cirrhosis is a serious condition. It damages the liver over time. Common causes include alcohol, hepatitis, and fatty ...

The global progressive pulmonary fibrosis (PPF) treatment market is projected to be valued at USD 4,044.6 Million in 2025 and is expected to reach USD 8,182.4 Million by 2035, registering a CAGR of 7.

Rentosertib, an AI-generated small molecule targeting Traf2- and Nck-interacting kinase, was safe and improved FVC in ...

TAIPEI (Taiwan News) — A team formed by National Central University, Taipei Veterans General Hospital, and National Yang Ming ...

Chronic colonization by filamentous fungi in patients with cystic fibrosis (pwCF) is linked to declines in lung function and quality of life. To better assess indoor mold exposure, 23 French dwellings ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The study assessed 694 individuals who underwent cardiac MRI between 2018 and 2022 at a single UK centre. This cohort ...

Let’s take a look at 7 dangerous things that can happen to your body when fatty liver progresses and your liver is under ...

Prime Medicine, Inc. achieved strong early data in CGD with PM359, surpassing efficacy thresholds. Click here to find out why ...

Ning Zhao develops tool to track proteins, offering a better understanding of cell mechanisms to help combat diseasesHave you ...

In a June 24, 2025, podcast, Goldman Sachs’ Christian Mueller-Glissmann and Alexandra Wilson-Elizondo examined the dynamics ...